WSMI was invited to participate to the Asia-Pacific Economic Cooperation Life Sciences Innovation Forum’s (APEC LSIF) drug safety and detection technology which took place in Beijing, China from September 27 to 28, 2011. This APEC LSIF project is led by the United-States and China, with Singapore, Peru and Mexico as co-sponsor APEC Economies. The event partners in China are State Food and Drug Administration of China (SFDA) and the China National Institutes for Food and Drug Control (NIFDC).
The workshop was entitled “building international cooperation to protect patients”. It built upon previous APEC seminars to promote safe medicines, which have focused on cooperation and strategies to combat counterfeiting and promote the quality of medicines. These seminars drew strong interest and led to cooperative activities related to combating the spread of counterfeit medicines and improving drug quality. Seminar participants included regulators, industry representatives, as well as customs, law enforcement and judicial officials. WSMI presented on the perspectives of the OTC industry on detection technologies. The particularities of the OTC sector, high volume, low margin, wider retail distribution determine the useable anti-counterfeiting technologies in general and detection technologies in particular.